
    
      The study was conducted as an open label, balanced, randomised, two-treatment, two-period,
      two-sequence, single-dose, crossover , bioequivalence study on minocycline comparing
      minocycline 100mg tablets of Ranbaxy pharmaceuticals inc with Minocin 100mg capsules of in
      healthy, adult, human, subjects under fasting conditions.

      A total of 28 non-smoking subjects (16 men and 12 women) were included in this study, of
      which 28 finished the study according to the protocol,
    
  